27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

Analyst Stock Ratings Downgrades

Analyst downgrades are often a bearish signal for a stock. When an analyst downgrades a stock it means the stock rating is lower than it previously was and the analyst likely does not recommend people buy the stock. Updated 05/17/2024

Buy NowGet Alert
05/17/2024CBRLBuy Now
Cracker Barrel Old
$49.76—CL King
Andrew Wolf48%
—DowngradeBuy → NeutralGet Alert
05/17/2024TTWOBuy Now
Take-Two Interactive
$146.994.77%HSBC
Mohammed Khallouf48%
 → $154DowngradeBuy → HoldGet Alert
05/17/2024MACBuy Now
Macerich
$15.54-9.94%Scotiabank
Greg McGinniss52%
$16 → $14DowngradeSector Perform → Sector UnderperformGet Alert
05/17/2024CPAYBuy Now
Corpay
$280.045.34%Wolfe Research
Darrin Peller73%
 → $295DowngradePeer Perform → UnderperformGet Alert
05/17/2024EPAMBuy Now
EPAM Sys
$187.02—Wolfe Research
Darrin Peller73%
—DowngradeOutperform → Peer PerformGet Alert
05/17/2024LADBuy Now
Lithia Motors
$268.56—Guggenheim
Ali Faghri78%
—DowngradeBuy → NeutralGet Alert
05/17/2024BIDUBuy Now
Baidu
$111.2012.41%Morgan Stanley
Gary Yu54%
$140 → $125DowngradeOverweight → Equal-WeightGet Alert
05/17/2024WBBuy Now
Weibo
$9.604.22%Morgan Stanley
Alex Poon76%
$11 → $10DowngradeEqual-Weight → UnderweightGet Alert
05/17/2024BMRNBuy Now
Biomarin Pharmaceutical
$77.60-7.22%Baird
Joel Beatty72%
$104 → $72DowngradeOutperform → NeutralGet Alert
05/16/2024NOTVBuy Now
Inotiv
$1.895.82%Lake Street
Frank Takkinen34%
$10 → $2DowngradeBuy → HoldGet Alert
05/16/2024PBLABuy Now
Panbela Therapeutics
$0.43—HC Wainwright & Co.
Joseph Pantginis57%
—DowngradeBuy → NeutralGet Alert
05/16/2024UAABuy Now
Under Armour
$6.80—William Blair
Sharon Zackfia56%
—DowngradeOutperform → Market PerformGet Alert
05/16/2024TMCIBuy Now
Treace Medical Concepts
$5.1326.83%UBS
Danielle Antalffy62%
$16 → $6.5DowngradeBuy → NeutralGet Alert
05/16/2024VLOBuy Now
Valero Energy
$164.25—Argus Research
Bill Selesky75%
—DowngradeBuy → HoldGet Alert
05/16/2024CRUSBuy Now
Cirrus Logic
$110.56—Benchmark
David Williams50%
—DowngradeBuy → HoldGet Alert
05/16/2024OXYBuy Now
Occidental Petroleum
$63.239.13%Truist Securities
Neal Dingmann52%
$84 → $69DowngradeBuy → HoldGet Alert
05/16/2024EOGBuy Now
EOG Resources
$128.685.69%Truist Securities
Neal Dingmann52%
$163 → $136DowngradeBuy → HoldGet Alert
05/15/2024CSWCBuy Now
Capital Southwest
$26.09—JMP Securities
Devin Ryan79%
—DowngradeMarket Outperform → Market PerformGet Alert
05/15/2024CTNTBuy Now
Cheetah Net Supply Chain
$9.71—Maxim Group
Tate Sullivan58%
—DowngradeBuy → HoldGet Alert
05/15/2024LUXHBuy Now
LuxUrban Hotels
$0.51—Maxim Group
Allen Klee34%
—DowngradeBuy → HoldGet Alert
05/15/2024OMABBuy Now
Central North Airport Gr
$88.66—Scotiabank
Francisco Suarez52%
—DowngradeSector Perform → Sector UnderperformGet Alert
05/15/2024BOLTBuy Now
Bolt Biotherapeutics
$0.8222.59%Leerink Partners
Daina Graybosch45%
$3 → $1DowngradeOutperform → Market PerformGet Alert
05/15/2024AIGBuy Now
American Intl Gr
$80.476.87%HSBC
Vikram Gandhi61%
 → $86DowngradeBuy → HoldGet Alert
05/15/2024DNABuy Now
Ginkgo Bioworks Holdings
$0.81—BTIG
Mark Massaro41%
—DowngradeNeutral → SellGet Alert
05/15/2024RLYBBuy Now
Rallybio
$1.81—JP Morgan
Anupam Rama64%
—DowngradeOverweight → NeutralGet Alert
05/15/2024AMPSBuy Now
Altus Power
$3.98—JP Morgan
Mark Strouse64%
—DowngradeOverweight → NeutralGet Alert
05/15/2024BOLTBuy Now
Bolt Biotherapeutics
$0.82—Jones Trading
Soumit Roy33%
—DowngradeBuy → HoldGet Alert
05/15/2024BOLTBuy Now
Bolt Biotherapeutics
$0.82—HC Wainwright & Co.
Edward White59%
—DowngradeBuy → NeutralGet Alert
05/15/2024PBRBuy Now
Petrobras Brasileiro
$15.1316.95%Jefferies
Alejandro Demichelis61%
$21.2 → $17.7DowngradeBuy → HoldGet Alert
05/15/2024BSRRBuy Now
Sierra
$22.06—Janney Montgomery Scott
Timothy Coffey56%
—DowngradeBuy → NeutralGet Alert

Recent Analyst Stock Rating Downgrades News

Under Armour Is Lagging Behind Peers Like Nike & Lululemon! Analyst Explains Why
Under Armour faces challenges as it lags behind competitors, with analysts noting concerns over revenue decline, product innovation, and profitability.
CL King Downgrades Cracker Barrel Old to Neutral
CL King analyst Andrew Wolf downgrades Cracker Barrel Old (NASDAQ:CBRL) from Buy to Neutral.
HSBC Downgrades Take-Two Interactive to Hold, Announces $154 Price Target
HSBC analyst Mohammed Khallouf downgrades Take-Two Interactive (NASDAQ:TTWO) from Buy to Hold and announces $154 price target.
Scotiabank Downgrades Macerich to Sector Underperform, Lowers Price Target to $14
Scotiabank analyst Greg McGinniss downgrades Macerich (NYSE:MAC) from Sector Perform to Sector Underperform and lowers the price target from $16 to $14.
Wolfe Research Downgrades Corpay to Underperform, Announces $295 Price Target
Wolfe Research analyst Darrin Peller downgrades Corpay (NYSE:CPAY) from Peer Perform to Underperform and announces $295 price target.
Wolfe Research Downgrades EPAM Sys to Peer Perform
Wolfe Research analyst Darrin Peller downgrades EPAM Sys (NYSE:EPAM) from Outperform to Peer Perform.
Guggenheim Downgrades Lithia Motors to Neutral
Guggenheim analyst Ali Faghri downgrades Lithia Motors (NYSE:LAD) from Buy to Neutral.
Morgan Stanley Downgrades Baidu to Equal-Weight, Lowers Price Target to $125
Morgan Stanley analyst Gary Yu downgrades Baidu (NASDAQ:BIDU) from Overweight to Equal-Weight and lowers the price target from $140 to $125.
Morgan Stanley Downgrades Weibo to Underweight, Lowers Price Target to $10
Morgan Stanley analyst Alex Poon downgrades Weibo (NASDAQ:WB) from Equal-Weight to Underweight and lowers the price target from $11 to $10.
Baird Downgrades Biomarin Pharmaceutical to Neutral, Lowers Price Target to $72
Baird analyst Joel Beatty downgrades Biomarin Pharmaceutical (NASDAQ:BMRN) from Outperform to Neutral and lowers the price target from $104 to $72.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free